There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next ...

Although mpMRI can improve targeting of clinically significant prostate cancer, its performance depends in part on obtaining ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Preoperative MRI-based T staging demonstrated oncologic risk discrimination comparable to traditional digital rectal examinations (DREs) for predicting survival outcomes in men with clinically ...

Targeting men in the top 10% of genetic risk helped detect high-grade prostate cancer that conventional screening would miss, paving the way for more personalized and effective early detection ...

Omitting biopsy in patients with a negative prostate MRI more than halves the diagnoses of clinically insignificant prostate cancer. Detection of clinically insignificant ISUP grade group 1 prostate ...

Public event brings together a radiologist, urologist and robotic surgeon, and a prostate cancer survivor for an informative ...